Copyright Reports & Markets. All rights reserved.

Global Organoid Matrix Gel Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Organoid Matrix Gel Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Contains Phenol Red
    • 1.3.3 Phenol Red Free
  • 1.4 Market Analysis by Sales Channel
    • 1.4.1 Overview: Global Organoid Matrix Gel Consumption Value by Sales Channel: 2021 Versus 2025 Versus 2032
    • 1.4.2 Direct Selling
    • 1.4.3 Distribution
  • 1.5 Market Analysis by Application
    • 1.5.1 Overview: Global Organoid Matrix Gel Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Scientific Research
    • 1.5.3 Clinical
    • 1.5.4 R&D
  • 1.6 Global Organoid Matrix Gel Market Size & Forecast
    • 1.6.1 Global Organoid Matrix Gel Consumption Value (2021 & 2025 & 2032)
    • 1.6.2 Global Organoid Matrix Gel Sales Quantity (2021-2032)
    • 1.6.3 Global Organoid Matrix Gel Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Corning
    • 2.1.1 Corning Details
    • 2.1.2 Corning Major Business
    • 2.1.3 Corning Organoid Matrix Gel Product and Services
    • 2.1.4 Corning Organoid Matrix Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Corning Recent Developments/Updates
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific Organoid Matrix Gel Product and Services
    • 2.2.4 Thermo Fisher Scientific Organoid Matrix Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.3 Bio-Techne
    • 2.3.1 Bio-Techne Details
    • 2.3.2 Bio-Techne Major Business
    • 2.3.3 Bio-Techne Organoid Matrix Gel Product and Services
    • 2.3.4 Bio-Techne Organoid Matrix Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Bio-Techne Recent Developments/Updates
  • 2.4 ACROBiosystems
    • 2.4.1 ACROBiosystems Details
    • 2.4.2 ACROBiosystems Major Business
    • 2.4.3 ACROBiosystems Organoid Matrix Gel Product and Services
    • 2.4.4 ACROBiosystems Organoid Matrix Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 ACROBiosystems Recent Developments/Updates
  • 2.5 Mogengel Biotechnology
    • 2.5.1 Mogengel Biotechnology Details
    • 2.5.2 Mogengel Biotechnology Major Business
    • 2.5.3 Mogengel Biotechnology Organoid Matrix Gel Product and Services
    • 2.5.4 Mogengel Biotechnology Organoid Matrix Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Mogengel Biotechnology Recent Developments/Updates
  • 2.6 Yeasen Biotechnology
    • 2.6.1 Yeasen Biotechnology Details
    • 2.6.2 Yeasen Biotechnology Major Business
    • 2.6.3 Yeasen Biotechnology Organoid Matrix Gel Product and Services
    • 2.6.4 Yeasen Biotechnology Organoid Matrix Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Yeasen Biotechnology Recent Developments/Updates
  • 2.7 bioGenous
    • 2.7.1 bioGenous Details
    • 2.7.2 bioGenous Major Business
    • 2.7.3 bioGenous Organoid Matrix Gel Product and Services
    • 2.7.4 bioGenous Organoid Matrix Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 bioGenous Recent Developments/Updates
  • 2.8 Beyotime
    • 2.8.1 Beyotime Details
    • 2.8.2 Beyotime Major Business
    • 2.8.3 Beyotime Organoid Matrix Gel Product and Services
    • 2.8.4 Beyotime Organoid Matrix Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Beyotime Recent Developments/Updates
  • 2.9 K2 ONCOLOGY
    • 2.9.1 K2 ONCOLOGY Details
    • 2.9.2 K2 ONCOLOGY Major Business
    • 2.9.3 K2 ONCOLOGY Organoid Matrix Gel Product and Services
    • 2.9.4 K2 ONCOLOGY Organoid Matrix Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 K2 ONCOLOGY Recent Developments/Updates
  • 2.10 D1 MEDICAL TECHNOLOGY
    • 2.10.1 D1 MEDICAL TECHNOLOGY Details
    • 2.10.2 D1 MEDICAL TECHNOLOGY Major Business
    • 2.10.3 D1 MEDICAL TECHNOLOGY Organoid Matrix Gel Product and Services
    • 2.10.4 D1 MEDICAL TECHNOLOGY Organoid Matrix Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 D1 MEDICAL TECHNOLOGY Recent Developments/Updates

3 Competitive Environment: Organoid Matrix Gel by Manufacturer

  • 3.1 Global Organoid Matrix Gel Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Organoid Matrix Gel Revenue by Manufacturer (2021-2026)
  • 3.3 Global Organoid Matrix Gel Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Organoid Matrix Gel by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Organoid Matrix Gel Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Organoid Matrix Gel Manufacturer Market Share in 2025
  • 3.5 Organoid Matrix Gel Market: Overall Company Footprint Analysis
    • 3.5.1 Organoid Matrix Gel Market: Region Footprint
    • 3.5.2 Organoid Matrix Gel Market: Company Product Type Footprint
    • 3.5.3 Organoid Matrix Gel Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Organoid Matrix Gel Market Size by Region
    • 4.1.1 Global Organoid Matrix Gel Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Organoid Matrix Gel Consumption Value by Region (2021-2032)
    • 4.1.3 Global Organoid Matrix Gel Average Price by Region (2021-2032)
  • 4.2 North America Organoid Matrix Gel Consumption Value (2021-2032)
  • 4.3 Europe Organoid Matrix Gel Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Organoid Matrix Gel Consumption Value (2021-2032)
  • 4.5 South America Organoid Matrix Gel Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Organoid Matrix Gel Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Organoid Matrix Gel Sales Quantity by Type (2021-2032)
  • 5.2 Global Organoid Matrix Gel Consumption Value by Type (2021-2032)
  • 5.3 Global Organoid Matrix Gel Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Organoid Matrix Gel Sales Quantity by Application (2021-2032)
  • 6.2 Global Organoid Matrix Gel Consumption Value by Application (2021-2032)
  • 6.3 Global Organoid Matrix Gel Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Organoid Matrix Gel Sales Quantity by Type (2021-2032)
  • 7.2 North America Organoid Matrix Gel Sales Quantity by Application (2021-2032)
  • 7.3 North America Organoid Matrix Gel Market Size by Country
    • 7.3.1 North America Organoid Matrix Gel Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Organoid Matrix Gel Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Organoid Matrix Gel Sales Quantity by Type (2021-2032)
  • 8.2 Europe Organoid Matrix Gel Sales Quantity by Application (2021-2032)
  • 8.3 Europe Organoid Matrix Gel Market Size by Country
    • 8.3.1 Europe Organoid Matrix Gel Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Organoid Matrix Gel Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Organoid Matrix Gel Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Organoid Matrix Gel Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Organoid Matrix Gel Market Size by Region
    • 9.3.1 Asia-Pacific Organoid Matrix Gel Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Organoid Matrix Gel Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Organoid Matrix Gel Sales Quantity by Type (2021-2032)
  • 10.2 South America Organoid Matrix Gel Sales Quantity by Application (2021-2032)
  • 10.3 South America Organoid Matrix Gel Market Size by Country
    • 10.3.1 South America Organoid Matrix Gel Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Organoid Matrix Gel Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Organoid Matrix Gel Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Organoid Matrix Gel Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Organoid Matrix Gel Market Size by Country
    • 11.3.1 Middle East & Africa Organoid Matrix Gel Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Organoid Matrix Gel Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Organoid Matrix Gel Market Drivers
  • 12.2 Organoid Matrix Gel Market Restraints
  • 12.3 Organoid Matrix Gel Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Organoid Matrix Gel and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Organoid Matrix Gel
  • 13.3 Organoid Matrix Gel Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Organoid Matrix Gel Typical Distributors
  • 14.3 Organoid Matrix Gel Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Organoid Matrix Gel market size was valued at US$ 43.47 million in 2025 and is forecast to a readjusted size of US$ 160 million by 2032 with a CAGR of 19.8% during review period.
    Organoid matrix gel typically refers to an EHS-tumor–derived soluble basement membrane extract (BME), exemplified by Matrigel, Geltrex and Cultrex. It is enriched in laminin, collagen IV, entactin/nidogen and heparan sulfate proteoglycans; it remains liquid on ice and polymerizes into a hydrogel at 37 °C, recreating a basement-membrane-like 3D ECM niche that supports organoid/tumoroid establishment, differentiation and long-term passaging.
    Upstream, organoid matrix gels rely on an EHS mouse sarcoma tumor bio-source and a BME (“whole-tumor/basement-membrane extract”) manufacturing backbone, with extraction, clarification/concentration, and sterile fill-finish typically performed under tight cold-chain temperature control.
    In 2025, global organoid matrix gel production reached approximately 1,000 liters, with an average global market price is $45 per ml.
    This report is a detailed and comprehensive analysis for global Organoid Matrix Gel market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Organoid Matrix Gel market size and forecasts, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/L), 2021-2032
    Global Organoid Matrix Gel market size and forecasts by region and country, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/L), 2021-2032
    Global Organoid Matrix Gel market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/L), 2021-2032
    Global Organoid Matrix Gel market shares of main players, shipments in revenue ($ Million), sales quantity (L), and ASP (US$/L), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Organoid Matrix Gel
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Organoid Matrix Gel market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Corning, Thermo Fisher Scientific, Bio-Techne, ACROBiosystems, Mogengel Biotechnology, Yeasen Biotechnology, bioGenous, Beyotime, K2 ONCOLOGY, D1 MEDICAL TECHNOLOGY, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Organoid Matrix Gel market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Contains Phenol Red
    Phenol Red Free
    Market segment by Sales Channel
    Direct Selling
    Distribution
    Market segment by Application
    Scientific Research
    Clinical
    R&D
    Major players covered
    Corning
    Thermo Fisher Scientific
    Bio-Techne
    ACROBiosystems
    Mogengel Biotechnology
    Yeasen Biotechnology
    bioGenous
    Beyotime
    K2 ONCOLOGY
    D1 MEDICAL TECHNOLOGY
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Organoid Matrix Gel product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Organoid Matrix Gel, with price, sales quantity, revenue, and global market share of Organoid Matrix Gel from 2021 to 2026.
    Chapter 3, the Organoid Matrix Gel competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Organoid Matrix Gel breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Organoid Matrix Gel market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Organoid Matrix Gel.
    Chapter 14 and 15, to describe Organoid Matrix Gel sales channel, distributors, customers, research findings and conclusion.

    Buy now